R&D Specialist, Oncology
- Employer
- Regeneron Pharmaceuticals, Inc.
- Location
- Tarrytown, New York
- Start date
- Aug 31, 2022
View more
- Discipline
- Clinical, Clinical Medicine, Science/R&D, Oncology
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Pharm Country, Best Places to Work
Job Details
We are seeking a Research Specialist to join the Oncology group. You will be part of a group responsible for the identification and validation of novel tumor drug targets and for the screening of fully-human antibodies (generated with our proprietary VelocImmune technology) against these targets.
In this role, a typical day may include:
Perform experiments including in vitro cell culture and in vivo tumor experiments in mice
Analyze data and communicate results clearly and concisely
Organize and compile results into a finished format for presentation
Maintain precise lab notebooks
Daily lab maintenance (e.g., ordering reagents and supplies)
This role may be for you if you:
Hardworking, highly organized with an attention to detail, flexible, and able to function effectively in a fast-paced environment
Excellent communication skills and be able to work well in a team
Expertise with in vitro tissue culture, cell-based and molecular biology assays as well as in vivo tumor models is highly desirable.
To be considered for this role you must have a BS or MS with at least 3 years of relevant work experience. We need someone with experience with large amounts of mammalian cell culture, as well as basic molecular biology and biochemistry techniques. Experience designing FACS panels and performing multi-color FACS analysis preferred but we are willing to train. Familiarity with CRISPR screens preferred but not required. Experience with mouse tumor models (e.g., subcutaneous implantation, drug dosing, measuring tumors and tumor harvest) is preferred but not required.
Company
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
Stock Symbol: REGN
Stock Exchange: NASDAQ
- Website
- https://www.regeneron.com/
- Phone
- 914-847-7000
- Location
-
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert